StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.38+0.04 (+12.53%)

Close on Nov 17, 2026Market cap $48.77MP/E –Yield –

Oncolytics Biotech EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2024 it was -0.41 CAD. The highest annual figure on record is -0.41 CAD in fiscal 2023.

Annual eps

PeriodPeriod endValueChange
FY2024Dec 31, 2024-0.41 CAD–
FY2023Dec 31, 2023-0.41 CAD–
FY2022Dec 31, 2022-0.43 CAD–
FY2021Dec 31, 2021-0.49 CAD–
FY2020Dec 31, 2020-0.56 CAD–
FY2019Dec 31, 2019-1.50 CAD–
FY2018Dec 31, 2018-1.06 CAD–
FY2017Dec 31, 2017-1.12 CAD–
FY2016Dec 31, 2016-1.20 CAD–
FY2015Dec 31, 2015-1.14 CAD–

More Oncolytics Biotech figures

See a number that looks wrong?